1[1]KleihuesP,CaveneeWK. Pathology and Genetics of Tumors of the Nervous System: World Health Organization Classification of Tu mors. Lyon: IARC Press, 2000:6～7,227～30
2[2]Ahlsen G, Gillberg IC, Lindblom R et al. Tuberous sclerosis in western Sweden. A population study of cases with early childhood onset. Arch Neurol , 1994:51:76～81
3[3]Roach ES, Smith M, Huttenlocher P et al. Diagnostic criteria: tuberous sclerosis complex. Report of the diagnostic criteria committee of the national tuberous sclerosis association. J Child Neurol,1992;7:221～4
4[4]Shepherd CW, Scheithauer BW, Gomez MR et al. Subependymal giant cell astrocytoma, a clinical pathological and flow cytometric study. Neurosurgery, 1991 ;28:864～8
5[5]Gyure KA, Prayson RA. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB-45 and MIB-1 immunohistoche mistry. Mod Pathol, 1997;10:313～7
6[6]Lantos PL, Vanden Berg SR, Kleihues P. Tumors of the Nervous System. In: Graham DI, Lantos PL eds. 6th ed, Greenfield' s Neuropathology. London:Arnold, 1997:583～879
7[7]Johnson MW, Emelin JK, Park SH et al. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis. Brain Pathol , 1999;9:45～54
8Borovich B, Doron Y, Braun J, et al. Recurrence of intracranial meningiomas: the role played by regional multicentricity. Part 2:Clinical and radiological aspects [ J ]. J Neurosurg, 1986, 65 (2) : 168-171.
9Mantle RE, Lach B, Delgado MR, et al. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning [ J]. J Neurosurg, 1999,91(3) : 375 -383.
10Yamasaki F, Yoshioka H, Hama S, et al. Recurrence of meningiomas[J]. Cancer, 2000, 89(5) : 1102 -1110.
